Loading
Loading
Biorank Laboratories
Non-Alcoholic Fatty Liver (NAFLD)
Educational purposes only. Not medical advice. Always consult your doctor before starting supplements.
Excess fat accumulation in the liver not caused by alcohol, linked to insulin resistance and metabolic dysfunction
Alysa Analysis for
Non-Alcoholic Fatty Liver (NAFLD)
Priority Guide
The PIVENS trial showed 800 IU/day improved liver histology in non-diabetic NASH patients. Reduces oxidative stress in hepatocytes.
Recommended Dose
400-800 IU mixed tocopherols daily
Expected Timeframe
24-96 weeks (long-term intervention)
No matching product in catalog yet. Search alternatives
Reduces hepatic triglyceride content and liver inflammation. Multiple RCTs show reduced liver fat on imaging.
Recommended Dose
2-4g combined EPA/DHA daily
Expected Timeframe
12-24 weeks
Reduces hepatic fat accumulation via AMPK activation. Improves insulin resistance, a core driver of NAFLD.
Recommended Dose
500mg twice daily with meals
Expected Timeframe
12-16 weeks
No matching product in catalog yet. Search alternatives
Hepatoprotective antioxidant. Some RCTs show reduced ALT/AST and improved liver histology.
Recommended Dose
420-600mg silymarin daily in divided doses
Expected Timeframe
12-24 weeks
No matching product in catalog yet. Search alternatives
1 of 4 supplements available in our database — add them all at once.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Always consult your doctor or qualified healthcare provider before starting any supplement regimen, especially if you have existing health conditions or take medications.
Supplements may interact with medications and are not intended to diagnose, treat, cure, or prevent any disease.
The evidence ratings reflect our analysis of published research and may not capture every nuance of individual health situations.